Entity Common Stock, Shares Outstanding of Maze Therapeutics, Inc. from 08 May 2025 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Maze Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 May 2025 to 03 Nov 2025.
  • Maze Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 48,119,444.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Maze Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 48,119,444 03 Nov 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 43,850,884 06 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 43,797,166 08 May 2025 10-Q 14 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.